FAMILIAL PULMONARY FIBROSIS
Clinical trials for FAMILIAL PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new FAMILIAL PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for FAMILIAL PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for families: new drug aims to stop lung scarring before it starts
Prevention Recruiting nowThis study tests whether the drug nerandomilast can slow or prevent lung scarring in people aged 40 and older who have early lung changes and a family history of pulmonary fibrosis. About 80 participants will take either nerandomilast or a placebo twice daily for up to 3 years. D…
Matched conditions: FAMILIAL PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Prevention
Last updated May 15, 2026 11:57 UTC
-
Family lung disease mystery: researchers track relatives to find clues
Knowledge-focused Recruiting nowThis study follows 750 close relatives of people with a rare, inherited form of lung scarring called familial pulmonary fibrosis. Participants have no symptoms yet but carry a higher genetic risk. Researchers will track their health over time with yearly surveys and in-person vis…
Matched conditions: FAMILIAL PULMONARY FIBROSIS
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 07:04 UTC
-
Scientists hunt for lung scarring genes in families
Knowledge-focused Recruiting nowThis study aims to find the genetic causes of familial pulmonary fibrosis, a lung disease that causes scarring and breathing problems. Researchers will analyze DNA from 126 adults from families where two or more close relatives have the condition. The goal is to identify gene cha…
Matched conditions: FAMILIAL PULMONARY FIBROSIS
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC